Latest Research Reports

Report: Bladder cancer market to grow at CAGR of 12.5% up to 2025

The bladder cancer market is expected to triple in size from $360m in 2015 to $1.1bn by 2025, witnessing a compound annual growth rate (CAGR) of 12.5%, according to a report by...

Report: Bladder cancer market to grow at CAGR of 12.5% up to 2025

Inorganic growth continues to fuel outsourcing sector

Inorganic growth continues to fuel outsourcing sector

Brazil: 2016 clinical trials activity at lowest point in five years

Brazil: 2016 clinical trials activity at lowest point in five years

Eylea enables Regeneron to dominate the ocular market

Eylea enables Regeneron to dominate the ocular market

Dark clouds: the growing burden of major depressive disorder

Dark clouds: the growing burden of major depressive disorder

UK’s young adults: using the web for medical advice

UK’s young adults: using the web for medical advice

Top pharma forecasted sales underestimated by analysts

Top pharma forecasted sales underestimated by analysts

Top oncology revenue generators: what will the next five years bring?

Top oncology revenue generators: what will the next five years bring?

Report: Companies adopting innovative strategies to compete in tauopathies space

Pharmaceutical companies are adopting shrewd strategies to effectively compete in the tauopathies space, observes a report by...

Report: Companies adopting innovative strategies to compete in tauopathies space

A serious threat on the horizon for Imbruvica

A serious threat on the horizon for Imbruvica

India’s 2016 clinical trials activity back to 2008 levels

India’s 2016 clinical trials activity back to 2008 levels

Biogen will retain the lion’s share of the neurology market

Biogen will retain the lion’s share of the neurology market

Seven kings of diabetes will remain in power for years to come

Seven kings of diabetes will remain in power for years to come

Novartis: most clinical trials initiated in a year

Novartis: most clinical trials initiated in a year

UK and Australian health authorities disagree over E-cigarettes

UK and Australian health authorities disagree over E-cigarettes

Detecting AML subtype the key to better targeted drugs

Detecting AML subtype the key to better targeted drugs

The growing burden of ART-resistant HIV

The growing burden of ART-resistant HIV

Surge in deals promises a brighter future for fatty liver disease

Deals involving drugs to treat fatty liver disease (FLD) hit an all-time high in 2016, with more than twice as many completed as in any year...

Surge in deals promises a brighter future for fatty liver disease

Non-profit licensing deal values climb in 2016

In 2016, there was a surge in deal values between the biopharmaceutical industry and non-profit...

Non-profit licensing deal values climb in 2016

Non-alcoholic steatohepatitis cases expected to nearly double over next decade

Non-alcoholic steatohepatitis (NASH) is a common, often clinically silent liver disease characterized by the presence of fat in the liver, in addition to liver inflammation and...

Non-alcoholic steatohepatitis cases expected to nearly double over next decade

Report: French pharmaceutical market to witness negative compound annual growth rate of 1% by 2021

The French pharmaceuticals market is projected to decline from $35.5bn in 2017 to $34.16bn in 2021, according to a report by...

Report: French pharmaceutical market to witness negative compound annual growth rate of 1% by 2021